BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Symonds JD, Zuberi SM. Genetics update: Monogenetics, polygene disorders and the quest for modifying genes. Neuropharmacology 2018;132:3-19. [PMID: 29037745 DOI: 10.1016/j.neuropharm.2017.10.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Zahra A, Wang Y, Wang Q, Wu J, Biagini G. Shared Etiology in Autism Spectrum Disorder and Epilepsy with Functional Disability. Behavioural Neurology 2022;2022:1-13. [DOI: 10.1155/2022/5893519] [Reference Citation Analysis]
2 Pavone P, Pappalardo XG, Mustafa N, Cho SY, Jin DK, Incorpora G, Falsaperla R, Marino SD, Corsello G, Parano E, Ruggieri M. Alternating Hemiplegia of Childhood: neurological comorbidities and intrafamilial variability. Ital J Pediatr 2022;48:29. [PMID: 35177115 DOI: 10.1186/s13052-021-01194-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Bagheri S, Haddadi R, Saki S, Kourosh-Arami M, Komaki A. The effect of sodium channels on neurological/neuronal disorders: A systematic review. Int J Dev Neurosci 2021. [PMID: 34687079 DOI: 10.1002/jdn.10153] [Reference Citation Analysis]
4 Carpenter JC, Lignani G. Gene Editing and Modulation: the Holy Grail for the Genetic Epilepsies? Neurotherapeutics 2021. [PMID: 34235638 DOI: 10.1007/s13311-021-01081-y] [Reference Citation Analysis]
5 Cao M, Wang L, Zhang L, Duan J. Global publication trends and hotspots of molecular biomarkers in DILI from 1991 to 2020: A 30-year bibliometric analysis. Sci Prog 2021;104:368504211000535. [PMID: 33749405 DOI: 10.1177/00368504211000535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Martinez-Moreno R, Selga E, Riuró H, Carreras D, Parnes M, Srinivasan C, Wangler MF, Pérez GJ, Scornik FS, Brugada R. An SCN1B Variant Affects Both Cardiac-Type (NaV1.5) and Brain-Type (NaV1.1) Sodium Currents and Contributes to Complex Concomitant Brain and Cardiac Disorders. Front Cell Dev Biol 2020;8:528742. [PMID: 33134290 DOI: 10.3389/fcell.2020.528742] [Reference Citation Analysis]
7 Salgueiro-pereira AR, Duprat F, Pousinha PA, Loucif A, Douchamps V, Regondi C, Ayrault M, Eugie M, Stunault MI, Escayg A, Goutagny R, Gnatkovsky V, Frassoni C, Marie H, Bethus I, Mantegazza M. A two-hit story: Seizures and genetic mutation interaction sets phenotype severity in SCN1A epilepsies. Neurobiology of Disease 2019;125:31-44. [DOI: 10.1016/j.nbd.2019.01.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 7.7] [Reference Citation Analysis]
8 Lauxmann S, Verbeek NE, Liu Y, Zaichuk M, Müller S, Lemke JR, van Kempen MJ, Lerche H, Hedrich UB. Relationship of electrophysiological dysfunction and clinical severity in SCN2A -related epilepsies. Human Mutation 2018;39:1942-56. [DOI: 10.1002/humu.23619] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
9 Schorge S. Channelopathies go above and beyond the channels. Neuropharmacology 2018;132:1-2. [PMID: 29454019 DOI: 10.1016/j.neuropharm.2018.02.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]